Exploring New Coformulated Options in HIV. Clinical Brief Series - QI&CPD - Category 2

Duration

1 hr

Profession

Physician

# of Credits

2.0

Accreditation

QI & CPD - Category 2

Expiry Date

2021-07-31

This is a 4-part Clinical Brief series that has been accredited with RACGP. Participants must read all 4 issues and then complete the questions on Issue 4 to claim CPD points.Please ensure that you have read all four parts of this Clinical Brief series, then complete the following 5 questions in order to claim your CPD points.The aim of this Clinical Brief series is to help S100 Prescribers and GPs review the pharmacokinetic profiles of HIV drug regimens and use this information to assess the risks and benefits of various polydrug regimens given patients' comorbidities and HIV status.

This activity has been approved by The Royal Australian College of General Practitioners QI&CPD Program. Total Points: 2.00 Point(s) (Category 2)

David Alain Wohl
MD, Professor of Medicine,
Institute of Global Health and Infectious Diseases,
University of North Carolina, Chapel Hill, NC, USA

David Baker
MBChB, Dip Med (Sexual Health)
Senior Lecturer, Notre Dame University, NSW
Director East Sydney Doctors, Darlinghurst, NSW
Medical Advisor to Australasian Society for HIV,
Viral Hepatitis and Sexual Health Medicine (ASHM)

On completion of this program, participants will be better able to:

  1. Review HIV comorbidities, and risk factors for comorbidities
  2. Outline the recommended regimens that can minimise comorbidities while optimising patient safety
  3. Discuss findings from recent studies regarding the efficacy and tolerability of B/F/TAF
  4. Identify optimal treatment choices for individual patients, considering older and newer treatment regimens and current guidelines


Related Courses